Search

everythinglearnresearchcommunity

for

Search:↓

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

PLD is an effective and safer alternative for treating breast cancer.

Endocrine therapies for cancer significantly increase the risk of hair loss.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.